Press Releases

AI & Medicine Releases Biomarker Discovery and Targeted Proteomics Services for Researchers

AI & Medicine Releases Biomarker Discovery and Targeted Proteomics Services for Researchers

Broad-spectrum Antiviral Drug Discovery Services Are Ready to Facilitate SARS-CoV-2 Research

Creative Biolabs has combined with integrated, multidisciplinary drug discovery expertise and unparalleled scope of capabilities in SARS-CoV-2 candidates screening, effective viral inhibitors discovery, therapeutic antibody development and vaccine exploration.

CD Genomics Upgrades Highly Accurate Single-Cell Sequencing Services for Genome Researchers and Projects

Creative Enzymes Launches Enzymes for Coronavirus Nucleic Acid Test to Help the Detection of COVID-19

TARA biosystems demonstrates in vitro cardiac biology model mimics human drug response

Boehringer Ingelheim Extends TrialScope Partnership

A customer since 2015, Boehringer Ingelheim has renewed its partnership with TrialScope for an additional five years.

TrialScope Expands Leadership Team with New Chief Commercial Officer

TrialScope, the global leader in clinical trial transparency, has hired Chris Venezia as Chief Commercial Officer, expanding its executive team.

CD Genomics Releases Kits and Reagents for Coronavirus Research to Aid in COVID-19 Response

Creative Proteomics Launches Several Newly-developed Services for Protein Related Projects

Creative Enzymes Introduces Newly-Developed Enzyme Products for Some Related Projects

Creative BioMart Enlarged Its Metabolism Proteins List

Profacgen Provides Pharmacophore Modeling for Drug Design

Creative Biostructure Updated Its Membrane Protein Service

Lifeasible Updated Its Physical Purity Testing Service for Seed Testing

Matexcel Updated Its Customized Polymerization Service

Customized Biodegradable Polymers Are Available at CD Bioparticles

Empowered by leading technology and years of experience in drug delivery, CD Bioparticles now integrate various kinds of biodegradable polymers into its all-inclusive array of products covering lipids, liposomes, biopolymers and synthetic polymers.

bioBoaVista manufactures customised media for COVID nasal diagnostic tests using the Flexicon PF7

bioBoaVista has developed a viral transport medium for more efficient nasal tests for the diagnosis of COVID-19 using the Flexicon PF7 bench top filling machine from Watson-Marlow Fluid Technology Group.

COVID-19 SCREENING IN IVF CLINICS: SAFETY IS THE PRIORITY

Inconsistencies in guidance for IVF clinics cause confusion, says Bourn Hall’s Medical Director

Creative Bioarray Unveils Comprehensive Histology Services to Accelerate The Projetcs in Biolinical Research

Shimmer Named 2020 Citeline Award Finalist for Its Verisense™ Continuous Monitoring Platform for Clinical Trials; Co-founding Open Wearables Initiative

Shimmer’s Verisense platform reliably captures accurate and complete biometric data, while placing minimum burden on clinical trial sponsors, sites and participants. The Open Wearables Initiative (www.OWEAR.org) is an industry collaboration designed to promote the effective use of high-quality, sensor-generated measures of health in clinical research through the open sharing of algorithms and datasets.